Media Center

Al Hammadi Company for Development and Investment (Al Hammadi) was established in the Kingdom of Saudi Arabia as a limited liability Company under commercial registration number (1010196714) issued in 1425 AH (2004 AD) in Riyadh, and in 1429 AH (2008 AD), the ministerial decree (316/S) was issued to be converted to a Saudi closed joint stock Company.

ADS2

Company Announcements

December 5, 2018

Al Hammadi Company for Development and Investment announces that one of its fully owned subsidiaries has awarded to supply vaccines worth 20 million Saudi Riyals to Ministry of Health

ELEMENT LIST EXPLANATION Introduction Al Hammadi Company for Development and Investment announces that one of its fully owned subsidiaries has awarded to supply vaccines worth 20 million Saudi Riyals to Ministry of Health Date of Contract Award 2018-12-05 Corresponding to 1440-03-27 Contract Value 20 million riyal Expected Date of signing the contract 2019-03-31 Corresponding to […]

October 28, 2018

Al Hammadi Company for Development and Investment announces its interim Financial results for the period ending on 2018-09-30 ( Nine Months )

ELEMENT LIST CURRENT QUARTER SIMILAR QUARTER FOR PREVIOUS YEAR %CHANGE PREVIOUS QUARTER % CHANGE Sales/Revenue 250.39 163 53.613 214.49 16.737 Total Profit (Loss) 64.92 53.91 20.422 53.28 21.846 Profit (Loss) Operational 35.54 34.33 3.524 31.04 14.497 Net Profit (Loss) after Zakat and Tax 21.31 23.58 -9.626 19.93 6.924 Total Comprehensive Income 21.52 23.2 -7.241 20.36 […]

September 2, 2018

Al Hammadi Announces the latest developments of the Memorandum of Understanding (MOU) signed with Sudair Pharma Company

In reference to the announcement of Al Hammadi Company for Development and Investment published on Tadawul website on 10/10/1439H corresponding to 24/06/2018G regarding the extension of the Memorandum of Understanding (MOU) signed on April 21, 2018 with Sudair Pharma Company for the acquisition of an equity stake with the same terms and conditions until August […]

July 30, 2018

Al Hammadi Company for Development and Investment announces the interim financial results for the period ending on 30-06-2018 (Six Months)

ELEMENT CURRENT QUARTER SIMILAR QUARTER FOR PREVIOUS YEAR % CHANGE CURRENT PREVIOUS QUARTER % CHANGE PREVIOUS Net profit (loss) 19.93 25.66 -22.33 30.88 -35.46 Gross profit (loss) 53.28 58.15 -8.37 66.84 -20.29 Operational profit (loss) 31.04 33.85 -8.3 39.96 -22.32 All figures are in (Millions) Saudi Arabia, Riyals ELEMENT CURRENT PERIOD SIMILAR PERIOD FOR PREVIOUS […]

June 24, 2018

Addendum Announcement by Al Hammadi Company of Discontinuing the Preliminary Discussions with care in Relation to the Consideration of the Potential Merger of the Companies

With reference to the announcement made by Al Hammadi Company for Development and Investment on Tadawul website on 02/08/2018G with respect to its entry into preliminary discussions with the National Medical Care Company in relation to the consideration of the potential merger of the two companies, the Company announces that it has decided to discontinue […]

June 23, 2018

Addendum announcement from Al Hammadi Company for Development and Investment related to signing of a memorandum of understanding with Sudair Pharma Company for acquisition of equity stake.

Al Hammadi Company for Development and Investment announces that on Thursday the 21 June 2018 it extended the memorandum of understanding (MOU) signed on April 22 2018 with Sudair Pharma Company for the acquisition of an equity stake with the same conditions until August 31, 2018. Al Hammadi will announce in due course any further […]